The Patient Protection and Affordable Care Act saved consumers $1.7 billion on health insurance premiums last year, an HHS report found. Meanwhile, a separate study found that ACA provisions squeezed insurers' profits.
The Patient Protection and Affordable Care Act saved consumers $1.7 billion on health insurance premiums last year, an HHS report found. Meanwhile, a separate study found that ACA provisions squeezed insurers' profits.
The HHS report cites two provisions directly affecting health plan premiums—a rate review for premium increases that top 10% and the medical-loss ratio standard that caps how much of premium revenue insurers can use for administration, marketing and profits.
In its report Thursday, HHS cites an analysis from the Office of the Assistant Secretary for Planning and Evaluation, which found that in 2012, insurers requested smaller rate increases in the individual and small group markets.
Read the full story here: http://bit.ly/17UrKdy
Source: Modern Healthcare
The report said the average rate request in the individual insurance market dropped from 8.1% to 7.1%—a 12% decrease—and in the small group market, from 5.8% to 4.7%—a 19% drop. The data excluded the large group market.
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More